Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders
IntroductionCurrent approved COVID-19 vaccines, notably mRNA and adenoviral vectored technologies, still fail to fully protect against infection and transmission of various SARS-CoV-2 variants. The mucosal immunity at the upper respiratory tract represents the first line of defense against respirato...
Main Authors: | Jessica Denis, Annabelle Garnier, Laurence Cheutin, Audrey Ferrier, Hawa Timera, Fanny Jarjaval, Carine Hejl, Emmanuelle Billon-Denis, Percy ImmunoCovid group, Damien Ricard, Jean-Nicolas Tournier, Aurélie Trignol, Marie Mura |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1140714/full |
Similar Items
-
Managing Severe Dysgeusia and Dysosmia in Lung Cancer Patients: A Systematic Scoping Review
by: Ana Sofia Spencer, et al.
Published: (2021-11-01) -
Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in Japan
by: Yasuhiro Nakano, et al.
Published: (2022-10-01) -
The Long-Term Loss of Smell and Taste in COVID-19 Patients – A Systematic Review and Meta-Analysis
by: Jaqueline Dal Curtivo Passos, et al.
Published: (2024-05-01) -
Reduced olfactory performance is associated with changed microbial diversity, oralization, and accumulation of dead biomaterial in the nasal olfactory area
by: Christina Kumpitsch, et al.
Published: (2024-02-01) -
Factors associated with loss and recovery of smell and taste after COVID‐19 infection
by: Diego E. Razura, et al.
Published: (2024-10-01)